Company Filing History:
Years Active: 2021
Title: Yuichi Makinose: Innovator in Pharmaceutical Composition for Aortic Aneurysm Treatment
Introduction
Yuichi Makinose is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of aortic aneurysms. His innovative approach addresses critical medical challenges and showcases his dedication to improving patient care.
Latest Patents
Makinose holds a patent for a pharmaceutical composition aimed at treating abdominal aortic aneurysms. The invention provides a therapeutic agent that enables pharmacotherapy for this condition. The active component of the therapeutic agent is (−)-6-[3-[3-cyclopropyl-3-[(1R,2R)-2-hydroxycyclohexyl]ureido]propoxy]-2(1H)-quinolinone or a salt thereof, or a solvate of these. This patent represents a significant advancement in the medical field, offering new hope for patients suffering from this serious condition. He has 1 patent to his name.
Career Highlights
Throughout his career, Makinose has worked with esteemed institutions, including Hamamatsu University School of Medicine and Kowa Company Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Makinose has collaborated with notable colleagues, including Naoki Unno and Hiroki Tanaka. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work.
Conclusion
Yuichi Makinose is a distinguished inventor whose work in pharmaceutical compositions has the potential to transform the treatment of aortic aneurysms. His dedication to innovation and collaboration highlights the importance of research in advancing medical science.